Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans. - Wikidata - awgldk - TriplyDB

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

http://www.wikidata.org/entity/Q36427261

about

Ycasd - a tool for capturing and scaling data from graphical representations A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment.A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration.Modelling chemotherapy effects on granulopoiesis.Merging concepts - coupling an agent-based model of hematopoietic stem cells with an ODE model of granulopoiesis.A Biomathematical Model of Pneumococcal Lung Infection and Antibiotic Treatment in Mice Expression and function of hematopoiesis-stimulating factor receptors on the GPI(-) and GPI(+) hematopoietic stem cells of patients with paroxysmal nocturnal hemoglobinuria/aplastic anemia syndrome.Modelling c-Abl Signalling in Activated Neutrophils: the Anti-inflammatory Effect of Seliciclib A pharmacodynamic model of Bcr-Abl signalling in chronic myeloid leukaemia.Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.Closed form solutions and dominant elimination pathways of simultaneous first-order and Michaelis-Menten kinetics.Comparison and modelling of pegylated or unpegylated G-CSF schedules in CHOP-14 regimen of elderly patients with aggressive B-cell lymphoma.A Mathematical Model of Granulopoiesis Incorporating the Negative Feedback Dynamics and Kinetics of G-CSF/Neutrophil Binding and Internalization.Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.

P2860

Q28656042-11819566-38CD-4577-A9D7-4FDA81B2364F Q33712928-D5CD551F-4C32-44C1-B875-E561EEEAC5F4 Q34766672-AA98B081-D4A8-4AF6-9E60-6134AEB79560 Q34996295-7937B612-81E4-46DA-B8F7-CE6B9C0348DD Q35030415-87C386F5-7450-4317-9202-8CC5D749F1E7 Q36022465-6E9DC31F-4316-47D4-8723-161CD22E8BF4 Q36824622-13833282-F3FD-4EF9-950F-E3A5CF0AF65A Q38877559-09EA1C9F-6802-4F8F-9410-0AE63B848D13 Q46854633-76905834-6B11-42E6-B513-B362C45896FF Q47657705-21F4C37E-2E6F-43B6-B7B3-47A5106C39F5 Q47677277-22EC55AC-1AB4-4611-9900-9A13E1B5D79B Q47918300-680DAE3B-FB1A-4C5A-9D9B-9A3452B635C5 Q50561543-978D90F1-C50B-41B6-9AEF-194522E3D549 Q50611519-BDB80468-E048-48CB-8B97-CD573A847337 Q50878372-DC99F9FD-41E3-4475-BC1A-F087F1D00EA9

P2860

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

http://www.wikidata.org/entity/Q36427261

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

@ast

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

@en

type

label

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

@ast

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

@en

prefLabel

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

@ast

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

@en

P1433

Q36427261-A547EC2D-3FEC-4D25-8100-530BEED9E452

P1476

Q36427261-6A7CBD37-79DD-4C76-BDD2-6A4CC03C65E9

P2093

Q36427261-2A4D6DB3-6DC8-4E3E-906E-447A2617BD88

Q36427261-A20D80FD-B44D-4EB8-9E01-EC70FF3FF0AF

Q36427261-E7C6AECE-BAEE-42BC-93E1-008A8BA96B73

Q36427261-EB6D240A-4212-445A-BF37-D2390D16D6FC

P2860

Q36427261-05D0B77B-24C2-4931-A089-385C736A6CAD

Q36427261-0922A9FD-29DB-4E16-ABA5-9EFAD69C38E2

Q36427261-0FA065ED-74D3-4A61-9594-1E6D392339E3

Q36427261-203AED3A-CC12-43E1-ABA2-23AB7D50C812

Q36427261-22D580EA-14A1-4BAF-A380-D4C0D8C29D4D

Q36427261-28EE2A71-2054-47BF-AD69-0C4687EA75C1

Q36427261-2A6ACA86-0D2D-4053-A9AA-8D50AC0DCE23

Q36427261-2F1181D9-1CD3-4B0C-994F-71AD317EC015

Q36427261-3188C9AF-0C91-4623-A789-626566C08FA1

Q36427261-31D90449-F308-4F83-8F70-544563BB1C4F

P2888

Q36427261-B41BFC3D-B7CE-479F-8F87-164844519F07

P304

Q36427261-1A32DE6C-49B1-4ACD-B50C-B164756C6DA6

P31

Q36427261-4963641E-07A9-42D9-A267-FB3A9D839EEC

P356

Q36427261-0047981D-5FA6-4348-BC81-BDC8F883429A

P478

Q36427261-D197384E-D582-4F23-A079-0F0A6B433F0F

P50

Q36427261-0FF8CC87-EFC3-4A0C-8BFA-018B4305C415

P577

Q36427261-6BE6171D-3469-4FCE-BC5D-002B78ABC4E8

P5875

Q36427261-29258B1C-5E4E-4543-98AE-195C5CF4A4B1

P6179

Q36427261-BF1FC12C-AAF0-44CD-8599-CB14949E524D

P698

Q36427261-6DD70CAC-79B4-4023-883F-764C9115AF4F

P932

Q36427261-5ADB3B29-3ED7-41B6-8E1D-ACB9448E76A2

P356

P1433

Theoretical Biology and Medical Modelling

P1476

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

@en

P2093

Marcus Wetzler

http://www.w3.org/2001/XMLSchema#string

Markus Loeffler

http://www.w3.org/2001/XMLSchema#string

Markus Scholz

http://www.w3.org/2001/XMLSchema#string

Sibylle Schirm

http://www.w3.org/2001/XMLSchema#string

P2860

Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

Expression of G-CSF receptor on myeloid progenitors

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.

Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.

A biomathematical model of human thrombopoiesis under chemotherapy.

A glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study.

Effect of escalating doses of recombinant human granulocyte colony-stimulating factor (filgrastim) on circulating neutrophils in healthy subjects.

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

P2888

P304

32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4682-9-32

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Engel

P577

2012-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230587906

http://www.w3.org/2001/XMLSchema#string

P6179

1000282716

http://www.w3.org/2001/XMLSchema#string

P698

22846180

http://www.w3.org/2001/XMLSchema#string

P932

3507764

http://www.w3.org/2001/XMLSchema#string